Combination Treatment with a Novel Polyherbal Formulation and Metformin: A Single Blind Placebo-Controlled Study in Patients with T2DM and Cognitive Impairments

Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 4

Abstract

Background: Older people suffering from Type 2 Diabetes Mellitus (T2DM) are at major risk for age related cognitive dysfunction and dementia, mainly due to vascular complications. Studies have shown that T2DM is also associated with Alzheimer’s Disease (AD) and is responsible for accelerating the pathology through insulin resistance. A polyherbal drug containing Bacopa Monnieri, Hippophae rhamnoides and Dioscorea bulbifera has shown a potent neuroprotective effect in management of cognitive deficits in elderly; and metformin a well-accepted antidiabetic agent responsible for lowering blood glucose in T2DM, can together provide an intriguing potential combination therapy for prevention and amelioration of cognitive impairments in T2DM patients. Objective: The present study is aimed to evaluate the combined effect of a polyherbal drug and metformin on improving cognitive functions in patients suffering from T2DM. Method: Elderly patients with an age range of 60-75 years diagnosed for T2DM were enrolled in the study and randomized into two groups; Group I=T2DM patients given metformin and placebo, Group II=T2DM patients given metformin and polyherbal drug. The subjects received the combination therapy of metformin (500 mg) and placebo or metformin (500 mg) and polyherbal drug (500 mg) twice daily for a period of 24 weeks. Estimation of Mini Mental State Examination (MMSE) score, blood glucose, HbA1c, insulin, lipid profile (total cholesterol, LDL-c, HDL-c, triglycerides), homocysteine, Interleukin-6 (IL-6), TNF-α and C-reactive protein (CRP) were measured at baseline and were repeated at three months and six months. The primary end point was a change from baseline to week 24 in MMSE score. Key secondary end points included change from baseline to week 24 in Digital Symbol Substitution (DSS); subtest of the Wechsler Adult Intelligence Scale-Revised), word recall (digital memory apparatus – Medicaid systems, Chandigarh, India), attention span (Attention Span Apparatus – Medicaid systems, Chandigarh, India), Functional Activity Questionnaire (FAQ) and Hamilton Depression Scale (HDS) score. Further inflammatory markers and level of oxidative stress were analysed using standard biochemical tests. Result: The trial was performed in 120 elderly diabetic patients out of whom 112 patients completed the study for 24 weeks. Statistically significant differences were found between the two groups after intervention on cognitive performance indicated by MMSE, DSS, word recall, attention span, FAQ, HDS, and memory span scores; inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), Interferon-α (INF-α) and Tumor necrosis factor-α (TNF-α); oxidative stress markers like Superoxide dismutase (SOD), Glutathione peroxidase (GPx), Glutathione (GSH) and Thiobarbituric acid reactive substances (TBARS); and neurodegeneration marker Homocysteine (Hcy). However, no significant variations were indicated between groups in serum insulin and HbA1c levels after intervention of 24 weeks. Conclusion: The results of this study demonstrate the therapeutic potential of the combination therapy of a polyherbal drug and metformin. These results also support longer trials of this combination therapy for patients with mild cognitive impairment and diabetes.

Authors and Affiliations

Ananya Sadhu

Keywords

Related Articles

Behavioural Indicators as Risk of Diabetes Mellitus: A Community based Study in Manipur

Background: Diabetes Mellitus (DM) has become a major health issue all over the world. Lifestyle factors may affect the health of the patients with diabetes directly or indirectly. Family history of diabetes was given im...

NLRP3 Inflammasome Signaling Platform as New Pharmacological Target for Metaflammation

Metaflammation is a metabolic inflammatory state characterized by chronic, lowgrade inflammatory response initiated by excess nutrients in metabolic cells.1 The inflammatory signaling conducted by the metabolic cell eve...

Association of Total and Differential White Blood Cell Counts to Development of Type 2 Diabetes in Mexican Americans in Cameron County Hispanic Cohort

Objective: To evaluate the relationship between total and differential White Blood Cells (WBC) counts with time to transition to type 2 diabetes in Mexican Americans using prospective data from the Cameron County Hispani...

Substitution of Chronic Insulin Therapy with Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-transporter-2 Inhibitors

Insulin is a very useful and widely used treatment for diabetes. Temporary insulin therapy improves glucose toxicity due to improved β-cell function of the pancreas. Upon achieving glycemic control, insulin treatment cou...

Glycemic Variations after Ingestion of Different Carbohydrate-Containing Foods Assessed by Continuous Glucose Monitoring in Healthy and Diabetic Individuals in Daily Life

Carbohydrate counting is a meal planning approach for diabetic patients, but individual variations of the effect of glycemic index do not seem to be well taken into account. Here we assessed glycemic variations after the...

Download PDF file
  • EP ID EP550114
  • DOI 10.17140/DROJ-1-116
  • Views 102
  • Downloads 0

How To Cite

Ananya Sadhu (2015). Combination Treatment with a Novel Polyherbal Formulation and Metformin: A Single Blind Placebo-Controlled Study in Patients with T2DM and Cognitive Impairments. Diabetes Research – Open Journal, 1(4), 92-102. https://europub.co.uk/articles/-A-550114